Management of metastatic cutaneous melanoma: updates in clinical practice

In recent years, several drugs have been approved for the treatment of patients with metastatic cutaneous melanoma, completely reshaping the landscape of this aggressive disease. Immune therapy with cytotoxic T-lymphocyte antigen 4 and programmed cell death-1 inhibitors yielded significant and durab...

Descripción completa

Detalles Bibliográficos
Autores principales: Schvartsman, Gustavo, Taranto, Patricia, Glitza, Isabella C., Agarwala, Sanjiv S., Atkins, Michael B., Buzaid, Antonio C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6535734/
https://www.ncbi.nlm.nih.gov/pubmed/31205512
http://dx.doi.org/10.1177/1758835919851663

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6535734/
https://www.ncbi.nlm.nih.gov/pubmed/31205512
http://dx.doi.org/10.1177/1758835919851663

Ejemplares similares